|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
A genus-specific conventional cytochrome b (cytb) PCR has shown high sensitivity in field studies, detecting 70% submicroscopic malaria.
|
31276473 |
2019 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
Cytochrome b-nested PCR was used to detect malaria parasites from blood samples collected on a filter paper on day 3.
|
30860013 |
2019 |
|
Malaria
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This systematic review assesses the clinical efficacy of atovaquone/proguanil treatment of uncomplicated malaria and examines the extent to which codon 268 mutation in cytochrome b influences treatment failure and recrudescence based on published information.
|
29237012 |
2018 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
The phylogeny based on partial cytochrome b (cyt b) sequences suggests that this parasite is most closely related to Plasmodium tejerai (cyt b lineage pSPMAG01), a common malaria parasite of American birds.
|
28931453 |
2017 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using dried blood spot samples from patients with suspected malaria at 37 health facilities from 2012 to 2014 in the low-endemicity country of Swaziland, we investigated the diagnostic accuracy of histidine-rich protein 2-based RDTs using qualitative polymerase chain reaction (PCR) (nested PCR targeting the cytochrome b gene) and quantitative PCR as reference standards.
|
28369268 |
2017 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
Based on HRM analysis of vertebrate cytochrome b, 16S rRNA and COI PCR products, humans (72.36%) were the prominent blood-meal hosts of malaria vectors, but 20.91% of blood-meals were from non-human vertebrate hosts.
|
28886724 |
2017 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
SYBR Green real-time PCR-RFLP assay targeting the plasmodium cytochrome B gene--a highly sensitive molecular tool for malaria parasite detection and species determination.
|
25774805 |
2015 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
The prevalence of cytbPCR-detectable malaria infection was 2% (12 of 594), including 8 P. falciparum, 3 Plasmodium malariae, and 1 Plasmodium vivax infections.
|
23249688 |
2013 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
A cytochrome b (cytb) gene quantitative PCR (qPCR) assay was developed to diagnose malaria in travelers.
|
21508150 |
2011 |
|
Malaria
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
|
19021900 |
2008 |
|
Malaria
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The atovaquone resistance of malaria parasites correlates with mutations in the cytochrome b gene.
|
16690094 |
2006 |
|
Malaria
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The prevalence of codon-268 mutations in the cytb gene of African P. falciparum isolates from Nigeria, Malawi and Senegal, where atovaquone-proguanil has not been introduced for treatment of malaria was assessed.
|
17020611 |
2006 |
|
Malaria
|
0.100 |
Biomarker
|
disease |
BEFREE |
Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
|
14506774 |
2003 |